Medco Will Disclose Drug Cost After Rebates, Discounts Under Settlement
Executive Summary
Medco will disclose drug costs after rebates and discounts when the PBM wants to make a therapeutic interchange to a product with a higher AWP
You may also be interested in...
Medco class settlement remanded for review
A trial judge must determine whether the lead plaintiffs in a $42.5 mil. class action settlement with Medco had standing to bring the action, a New York-based federal appeals court ruled Dec. 8. The lower court failed to determine whether plaintiffs had demonstrated the required "injury-in-fact" necessary to gain standing to claim that Medco violated its fiduciary obligations, the appeals court said. The settlement, which was reached in 2002, faces objections from self-funded benefit plans that were Medco clients (1"The Pink Sheet" Dec. 16, 2002, p. 14)...
Medco class settlement remanded for review
A trial judge must determine whether the lead plaintiffs in a $42.5 mil. class action settlement with Medco had standing to bring the action, a New York-based federal appeals court ruled Dec. 8. The lower court failed to determine whether plaintiffs had demonstrated the required "injury-in-fact" necessary to gain standing to claim that Medco violated its fiduciary obligations, the appeals court said. The settlement, which was reached in 2002, faces objections from self-funded benefit plans that were Medco clients (1"The Pink Sheet" Dec. 16, 2002, p. 14)...
Medco Puts Number On DoJ Case: Settlement Should Be Less Than $42.5 Mil.
Medco hopes to resolve the Philadelphia U.S. Attorney's False Claims Act litigation for less than the $42.5 mil. the company has agreed to pay in a private class-action suit raising similar allegations